Edwards Lifesciences Corp (EW)

Precedente Chiudi:

$84.30

Aprire:

$84.9

Volume 24 ore:

254.02K

Capitalizzazione di mercato:

$50.80B

Reddito:

$6.14B

Utile/perdita netta:

$1.41B

Rapporto P/E:

36.32

EPS:

2.34

Flusso di cassa netto:

$251.20M

1 W Prestazione:

-3.39%

1M Prestazione:

-9.84%

6M Prestazione:

+29.76%

1 anno Prestazione:

-3.17%

Intervallo 1D:

$83.81

$85.09

Portata 52W:

$60.57

$96.12

Edwards Lifesciences Corp Stock (EW) Company Profile

Nome

Edwards Lifesciences Corp

Settore

Healthcare (1193)

Industria

Medical Devices (158)

Telefono

949-250-2500

Indirizzo

One Edwards Way, Irvine, CA

Dipendente

12,200

Cinguettio

@edwardslifesci

Prossima data di guadagno

2024-05-07

Ultimi documenti SEC

EW's Discussions on Twitter

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-02-02	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-01-04	Downgrade	Evercore ISI	Outperform → In-line
2023-12-11	Downgrade	Citigroup	Buy → Neutral
2023-11-28	Downgrade	Wolfe Research	Peer Perform → Underperform
2023-09-26	Aggiornamento	Oppenheimer	Perform → Outperform
2023-07-19	Iniziato	Robert W. Baird	Outperform
2023-05-30	Ripresa	Morgan Stanley	Overweight
2023-03-29	Iniziato	UBS	Neutral
2023-03-08	Downgrade	Wells Fargo	Overweight → Equal Weight
2023-02-06	Downgrade	Raymond James	Outperform → Mkt Perform
2023-01-31	Downgrade	Bernstein	Outperform → Underperform
2023-01-30	Downgrade	Piper Sandler	Overweight → Neutral
2022-12-06	Downgrade	Stifel	Buy → Hold
2022-10-28	Downgrade	Oppenheimer	Outperform → Perform
2022-10-26	Iniziato	Mizuho	Buy
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Buy
2022-07-29	Downgrade	Canaccord Genuity	Buy → Hold
2022-04-13	Iniziato	Truist	Buy
2022-04-06	Iniziato	Wolfe Research	Outperform
2022-03-16	Aggiornamento	Bernstein	Mkt Perform → Outperform
2022-03-02	Ripresa	BofA Securities	Neutral
2022-02-02	Aggiornamento	UBS	Neutral → Buy
2022-01-27	Reiterato	Citigroup	Buy
2022-01-27	Reiterato	Evercore ISI	Outperform
2022-01-27	Reiterato	Raymond James	Outperform
2022-01-27	Reiterato	Stifel	Buy
2022-01-27	Reiterato	UBS	Neutral
2021-12-17	Aggiornamento	JP Morgan	Neutral → Overweight
2021-12-15	Aggiornamento	Citigroup	Neutral → Buy
2021-12-10	Iniziato	RBC Capital Mkts	Outperform
2021-12-06	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2021-07-30	Reiterato	Canaccord Genuity	Buy
2021-07-30	Reiterato	Deutsche Bank	Hold
2021-07-30	Reiterato	Jefferies	Buy
2021-07-30	Reiterato	Morgan Stanley	Overweight
2021-07-30	Reiterato	Oppenheimer	Outperform
2021-07-30	Reiterato	Stifel	Buy
2021-07-30	Reiterato	UBS	Neutral
2021-07-30	Reiterato	Wells Fargo	Equal Weight
2021-05-25	Iniziato	Barclays	Overweight
2021-04-15	Iniziato	Atlantic Equities	Neutral
2021-04-05	Aggiornamento	Evercore ISI	In-line → Outperform
2020-12-16	Downgrade	Citigroup	Buy → Neutral
2020-12-11	Reiterato	Canaccord Genuity	Buy
2020-09-11	Iniziato	Wolfe Research	Underperform
2020-04-28	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-04-17	Aggiornamento	SVB Leerink	Mkt Perform → Outperform
2020-03-05	Iniziato	Citigroup	Buy
2020-02-13	Iniziato	Goldman	Neutral
2020-02-06	Ripresa	BTIG Research	Neutral
2020-01-10	Iniziato	Oppenheimer	Outperform
2020-01-02	Downgrade	Evercore ISI	Outperform → In-line
2019-10-24	Reiterato	Canaccord Genuity	Buy
2019-09-23	Iniziato	Piper Jaffray	Overweight
2019-07-24	Reiterato	BofA/Merrill	Buy
2019-03-18	Reiterato	Canaccord Genuity	Buy
2019-01-18	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-01-03	Iniziato	Deutsche Bank	Hold
2018-11-28	Iniziato	UBS	Neutral
2018-10-16	Iniziato	Barclays	Underweight
2018-10-02	Downgrade	BofA/Merrill	Buy → Neutral
2018-10-02	Downgrade	Guggenheim	Buy → Neutral

Mostra tutto

Edwards Lifesciences Corp Borsa (EW) Ultime notizie

Is Edwards Lifesciences (EW) Outperforming Other Medical Stocks This Year?

Zacks Investment Research

Down -10.22% in 4 Weeks, Here's Why You Should You Buy the Dip in Edwards Lifesciences (EW)

Zacks Investment Research

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks Investment Research

Investing in Edwards Lifesciences (EW)? Don't Miss Assessing Its International Revenue Trends

Zacks Investment Research

What's in Store for Cardinal Health (CAH) in Q3 Earnings?

Zacks Investment Research

Factors Setting the Tone For Lantheus' (LNTH) Q1 Earnings

Zacks Investment Research

Edwards Lifesciences Corp Azioni (EW) Dati Finanziari

Edwards Lifesciences Corp (EW) Reddito 2024

Edwards Lifesciences Corp (EW) Reddito netto 2024

Edwards Lifesciences Corp (EW) Flusso di cassa 2024

Edwards Lifesciences Corp (EW) Utile per azione 2024

Edwards Lifesciences Corp Azioni (EW) insider trading